Ago Ahene

602 total citations
16 papers, 434 citations indexed

About

Ago Ahene is a scholar working on Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Ago Ahene has authored 16 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Immunology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Ago Ahene's work include Biosimilars and Bioanalytical Methods (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Fibroblast Growth Factor Research (3 papers). Ago Ahene is often cited by papers focused on Biosimilars and Bioanalytical Methods (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Fibroblast Growth Factor Research (3 papers). Ago Ahene collaborates with scholars based in United States, Belgium and Switzerland. Ago Ahene's co-authors include Marian Kelley, Jihong Yang, Lindsay E. King, John Kamerud, Hossein Salimi-Moosavi, Jean W. Lee, Heather Myler, Meina Tang, Jianfeng Lü and Milan R. Uskoković and has published in prestigious journals such as Endocrinology, Antimicrobial Agents and Chemotherapy and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Ago Ahene

16 papers receiving 408 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ago Ahene United States 8 268 222 198 42 40 16 434
Katharina Diepold Germany 9 358 1.3× 64 0.3× 262 1.3× 35 0.8× 94 2.4× 11 540
S D Sanderson United States 12 293 1.1× 233 1.0× 91 0.5× 49 1.2× 12 0.3× 16 491
Lana J. Anderson United States 6 219 0.8× 204 0.9× 83 0.4× 123 2.9× 22 0.6× 7 513
Nathaniel C. Sears United States 8 337 1.3× 106 0.5× 43 0.2× 138 3.3× 42 1.1× 14 681
Ludovicus Staelens Belgium 12 230 0.9× 146 0.7× 236 1.2× 130 3.1× 6 0.1× 30 663
Shikiko Watanabe Belgium 11 141 0.5× 83 0.4× 81 0.4× 52 1.2× 28 0.7× 15 516
Sreekumar Kodangattil United States 7 231 0.9× 125 0.6× 196 1.0× 55 1.3× 14 0.3× 9 368
Lubna Abuqayyas United States 13 255 1.0× 141 0.6× 213 1.1× 81 1.9× 12 0.3× 19 522
Tamara Pittman United States 7 360 1.3× 116 0.5× 353 1.8× 37 0.9× 21 0.5× 7 496
Beth Coughlin United States 15 305 1.1× 246 1.1× 155 0.8× 13 0.3× 7 0.2× 18 710

Countries citing papers authored by Ago Ahene

Since Specialization
Citations

This map shows the geographic impact of Ago Ahene's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ago Ahene with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ago Ahene more than expected).

Fields of papers citing papers by Ago Ahene

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ago Ahene. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ago Ahene. The network helps show where Ago Ahene may publish in the future.

Co-authorship network of co-authors of Ago Ahene

This figure shows the co-authorship network connecting the top 25 collaborators of Ago Ahene. A scholar is included among the top collaborators of Ago Ahene based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ago Ahene. Ago Ahene is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Xiang, Hong, Lucy Liu, Yuying Gao, Ago Ahene, & Helen Collins. (2021). Covariate effects and population pharmacokinetic analysis of the anti-FGFR2b antibody bemarituzumab in patients from phase 1 to phase 2 trials. Cancer Chemotherapy and Pharmacology. 88(5). 899–910. 2 indexed citations
2.
Xiang, Hong, Ago Ahene, David I. Bellovin, et al.. (2021). Preclinical characterization of bemarituzumab, an anti-FGFR2b antibody for the treatment of cancer. mAbs. 13(1). 1981202–1981202. 26 indexed citations
3.
Xiang, Hong, Lucy Liu, Yuying Gao, et al.. (2020). Population pharmacokinetic analysis of phase 1 bemarituzumab data to support phase 2 gastroesophageal adenocarcinoma FIGHT trial. Cancer Chemotherapy and Pharmacology. 86(5). 595–606. 5 indexed citations
4.
Wong, David, Ago Ahene, Zachary Martinez, et al.. (2019). Pharmacokinetics of Human Recombinant Anti-Botulinum Toxin Antibodies in Rats. Toxins. 11(6). 345–345. 7 indexed citations
5.
Hsu, Amy, Hong Xiang, Ago Ahene, et al.. (2017). FPA150, a novel B7-H4 therapeutic antibody with checkpoint blockade and ADCC activities. Annals of Oncology. 28. v2–v2. 2 indexed citations
6.
Zhao, Jingsong, et al.. (2015). A Novel Allosteric Insulin Receptor–Activating Antibody Reduces Hyperglycemia without Hypoglycemia in Diabetic Cynomolgus Monkeys. Journal of Pharmacology and Experimental Therapeutics. 356(2). 466–473. 11 indexed citations
7.
Nayak, Seema, J. McLeod Griffiss, R. McKenzie, et al.. (2014). Safety and Pharmacokinetics of XOMA 3AB, a Novel Mixture of Three Monoclonal Antibodies against Botulinum Toxin A. Antimicrobial Agents and Chemotherapy. 58(9). 5047–5053. 47 indexed citations
8.
Liu, Xingrong, et al.. (2013). Pharmacokinetics and Pharmacodynamics of CD4-Anchoring Bi-Functional Fusion Inhibitor in Monkeys. Pharmaceutical Research. 31(3). 809–818. 3 indexed citations
9.
Ahene, Ago, Claudio Calonder, S. Scott Davis, et al.. (2013). Automation Practices in Large Molecule Bioanalysis: Recommendations from Group L5 of the Global Bioanalytical Consortium. The AAPS Journal. 16(1). 164–171. 3 indexed citations
10.
Kelley, Marian, Ago Ahene, Boris Gorovits, et al.. (2013). Theoretical Considerations and Practical Approaches to Address the Effect of Anti-drug Antibody (ADA) on Quantification of Biotherapeutics in Circulation. The AAPS Journal. 15(3). 646–658. 47 indexed citations
11.
Ahene, Ago, David W. Rusnak, Susan Spitz, et al.. (2012). Ligand Binding Assays in the 21st Century Laboratory: Automation. The AAPS Journal. 14(1). 142–153. 6 indexed citations
12.
13.
Ahene, Ago. (2011). Application and Interpretation of Free and Total Drug Measurements in the Development of Biologics. Bioanalysis. 3(11). 1287–1295. 19 indexed citations
15.
Peleg, Sara, Milan R. Uskoković, Ago Ahene, B. H. Vickery, & Zafrira Avnur. (2002). Cellular and Molecular Events Associated with the Bone-Protecting Activity of the Noncalcemic Vitamin D Analog Ro-26-9228 in Osteopenic Rats. Endocrinology. 143(5). 1625–1636. 35 indexed citations
16.
Ahene, Ago, et al.. (1986). Analysis and quantification of melanins: An immunological approach. Journal of Investigative Dermatology. 87(3). 396. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026